Daiichi Sankyo &AstraZeneca’s Enhertu approved in China as first HER2 directed medicine for patients with HER2 low or HER2 ultralow metastatic breast cancer ...
CBSE has released the exam schedule and city intimation slips for KVS and NVS recruitment exams scheduled for January 10 and ...